Modulation of ultra-low-molecular-weight heparin on [Ca 2+]i in nervous cells

Brain Research Bulletin

Volumn 86, Issue 5-6, 2011, Pages 355-359

  Hao, Lina ^a   Zhang, Qingzhu ^a   Yu, Tiangui ^b   Yu, Lihong ^a,b   Cheng, Yanna ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG MEDICAL COLLEGE   (China)

Author keywords

Alzheimer's disease; Apoptosis; Calcium dysregulation; Endoplasmic reticulum; Inositol 1,4,5 trisphosphate; Ultra low molecular weight heparin

Indexed keywords

CALCIUM ION; GLUTAMIC ACID; INOSITOL 1,4,5 TRISPHOSPHATE; LOW MOLECULAR WEIGHT HEPARIN; POTASSIUM ION; ULTRA LOW MOLECULAR WEIGHT HEPARIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CALCIUM SIGNALING; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; ENDOPLASMIC RETICULUM; EXTRACELLULAR SPACE; FEMALE; FLUORESCENCE ANALYSIS; MITOCHONDRION; NERVE CELL; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CALCIUM; CALCIUM SIGNALING; CELLS, CULTURED; ENDOPLASMIC RETICULUM; FLUORESCENT DYES; FURA-2; HEPARIN, LOW-MOLECULAR-WEIGHT; INOSITOL 1,4,5-TRISPHOSPHATE; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MITOCHONDRIA; NEURONS; RATS;

EID: 82755160718     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2011.08.018     Document Type: Article

References (30)

1. Bergamaschini L., Rossi E., Storini C., Pizzimenti S., Distaso M., Perego C., De Luigi A., Vergani C., De Simoni M.G. Peripheral treatment with enoxaparin, a low molecular weight heparin, reduces plaques and β-amyloid accumulation in a mouse model of Alzheimer's disease. J. Neurosci. 2004, 24:4181-4186.
2. Bezprozvanny I. Calcium signaling and neurodegenerative diseases. Trends Mol. Med. 2009, 15:89-100.
3. 2+ release from rat liver microsomes. FEBS Lett. 1988, 228:57-59.
4. Deepa P.R., Varalakshmi P. Influence of a low-molecular-weight heparin derivative on the nitric oxide levels and apoptotic DNA damage in adriamycin-induced cardiac and renal toxicity. Toxicology 2006, 217:176-183.
5. 3-mediated calcium signals and apoptosis: is there a role for Bcl-2?. Biochem. Soc. Trans. 2003, 31:958-959.
6. Frantseva M.V., Carlen P.L., Perez Velazquez J.L. Dynamics of intracellular calcium and free radical production during ischemia in pyramidal. Free Radical Biol. Med. 2001, 31:1216-1227.
7. Ghosh T.K., Eis P.S., Mullaney J.M., Ebert C.L., Gill D.L. Competitive, reversible, and potent antagonism of inositol 1,4,5-trisphosphate-activated calcium release by heparin. J. Biol. Chem. 1988, 263:11075-11079.
8. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 1985, 260:3440-3450.
9. Hertz E., Yua C.H., Hertz L., Juurlink B.H.J., Schousboe A. Preparation of primary cultures of mouse cortical neurons. A Dissection and Tissue Culture Manual of the Nervous System 1989, Alan R. Liss, New York. A. Shahar, J. De Vellis, A. Vernadakis, B. Haber (Eds.).
10. Hao L.N., Zhang Q.Z., Yu T.G., Cheng Y.N., Ji S.L. Antagonistic effects of ultra-low-molecular-weight heparin on Aβ25-35-induced apoptosis in cultured rat cortical neurons. Brain Res. 2011, 1368:1-10.
11. Kusakawa G., Saito T., Onuki R., Ishiguro K., Kishimoto T., Hisanaga S. Calpain-dependent proteolytic cleavage of the p35 cyclin-dependent kinase 5 activator to p25. J. Biol. Chem. 2000, 275:17166-17172.
12. Litersky J.M., Johnson G.V., Jakes R., Goedert M., Lee M., Seubert P. Tau protein is phosphorylated by cyclic AMP-dependent protein kinase and calcium/calmodulin-dependent protein kinase II within its microtubule-binding domains at Ser-262 and Ser-356. Biochem. J. 1996, 316:655-660.
13. Ma Q., Dudas B., Daud A., Iqbal O., Hoppensteadt D., Jeske W., Cornelli U., Lee J., Lorens S., Mervis R., Hanin I., Capila I., Linhardt R., Fareed J. Molecular and biochemical profiling of a heparin-derived oligosaccharide, C3. Thromb. Res. 2002, 105:303-309.
14. Ma Q., Dudas B., Hejna M., Cornelli U., Lee J.M., Lorens S., Mervis R., Hanin I., Fareed J. The blood-brain barrier accessibility of a heparin-derived oligosaccharides, C3. Thromb. Res. 2002, 105:447-453.
15. Maccioni R.B., Otth C., Concha I.I., Muñoz J.P. The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology. Eur. J. Biochem. 2001, 268:1518-1527.
16. Marambaud P., Dreses-Werringloer U., Vingtdeux V. Calcium signaling in neurodegeneration. Mol. Neurodegener. 2009, 4:20.
17. 2+ influx by unfractionated heparin in non-excitable intact cells via multiple mechanisms. Biochem. Pharmacol. 2005, 69:929-940.
18. Niers T.M., Klerk C.P., DiNisio M., Van Noorden C.J., Büller H.R., Reitsma P.H., Richel D.J. Mechanisms of heparin induced anti-cancer activity in experimental cancer models. Crit. Rev. Oncol. Hematol. 2007, 61:195-207.
19. Pierrot N., Ghisdal P., Caumont A.S., Octave J.N. Intraneuronal amyloid-beta1-42 production triggered by sustained increase of cytosolic calcium concentration induces neuronal death. J. Neurochem. 2004, 88:1140-1150.
20. Pierrot N., Santos S.F., Feyt C., Morel M., Brion J.P., Octave J.N. Calcium-mediated transient phosphorylation of tau and amyloid precursor protein followed by intraneuronal amyloid-beta accumulation. J. Biol. Chem. 2006, 281:39907-39914.
21. Shindo Y., Fujimoto A., Hotta K., Suzuki K., Oka K. Glutamate-induced calcium increase mediates magnesium release from mitochondria in rat hippocampal neurons. J. Neurosci. Res. 2010, 88:3125-3132.
22. 2+ signals and altered membrane excitability. J. Neurosci. 2004, 24:508-513.
23. Supnet C., Bezprozvanny I. The dysregulation of intracellular calcium in Alzheimer disease. Cell Calcium 2010, 47(2):183-189.
24. 3-linked mitochondrial calcium signals. EMBO J. 1999, 18:6349-6361.
25. 3-dependent intracellular calcium release in long-term potentiation in sympathetic ganglion of the rat. Synapse 2011, 65(5):441-448.
26. Vidugiriene J., Sharma D.K., Smith T.K., Baumann N.A., Menon A.K. Segregation of glycosylphosphatidylinositol biosynthetic reactions in a subcompartment of the endoplasmic reticulum. J. Biol. Chem. 1999, 274:15203-15212.
27. Walzer M., Lorens S., Hejna M., Fareed J., Hanin I., Cornelli U., Lee J.M. Low molecular weight glycosaminoglycan blockade of β-amyloid induced neuropathology. Eur. J. Pharmacol. 2002, 44:211-220.
28. Worley P.F., Baraban J.M., Supattapone S., Wilson V.S., Snyder S.H. Characterization of inositol trisphosphate receptor binding in brain. Regulation by pH and calcium. J. Biol. Chem. 1987, 262:12132-12136.
29. Yu J.T., Chang R.C., Tan L. Calcium dysregulation in Alzheimer's disease: from mechanisms to therapeutic opportunities. Prog. Neurobiol. 2009, 89:240-255.
30. Zhu H., Yu J., Kindy M.S. Inhibition of amyloidosis using low-molecular-weight heparins. Mol. Med. 2001, 7:517-522.